The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Jun Yang |
Young Investigator Grants |
2010 |
Tennessee |
Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing |
Children’s Hospital of Wisconsin - Milwaukee / Nathan Schloemer, MD |
Young Investigator Grants |
2016 |
Wisconsin |
Exosomes as Biomarkers to Monitor Disease Progression and Response to Therapy in Ewing sarcoma |
Children’s Mercy / Glenson Samuel, MD |
Young Investigator Grants |
2014 |
Missouri |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma |
Duke University / Michael Armstrong |
Young Investigator Grants |
2011 |
North Carolina |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD |
Young Investigator Grants |
2014 |
Washington |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children’s Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
Immunotherapy for Osteosarcoma and Ewing sarcoma
|
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Young Investigator Grants |
2007 |
Texas |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
Characterization and Targeting of Novel Activating BRAF Mutations in Pediatric Brain Tumors |
Children’s Hospital of Philadelphia / Angela Waanders, MD, MPH |
Young Investigator Grants |
2010 |
Pennsylvania |